Breast cancer is the second common cancer and the leading cause of malignancy among
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …

Breast cancer stem cells (BCSCs) are the minor population of breast cancer (BC) cells that
exhibit several phenotypes such as migration, invasion, self-renewal, and chemotherapy as …

Breast cancer (BC) is one of the most common malignant tumors in women globally, and its
occurrence has surpassed lung cancer and become the biggest threat for women. At …

Breast cancer is marked as one of the leading causes of malignancy-related morbidities
worldwide. In spite of aggressive interventions, the inevitability of relapse and metastasis …

Cancer stem cells (CSCs) are rare, tumour-initiating cells that exhibit stem cell properties:
capacity of self-renewal, pluripotency, highly tumorigenic po tential, and resistance to …

The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …

Both hereditary and sporadic breast cancer are suggested to develop from a stem cell
subcomponent retaining most key stem cell properties but with dysregulation of self-renewal …

Cancer metastasis, resistance to therapies and disease recurrence are significant hurdles to
successful treatment of breast cancer. Identifying mechanisms by which cancer spreads …

Breast cancers have been increasingly recognized as malignancies displaying frequent
inter-and intra-tumor heterogeneity. This heterogeneity is represented by diverse subtypes …

Abstract Development of therapeutic resistance and metastasis is a major challenge with
current breast cancer (BC) therapy. Mounting evidence suggests that a subpopulation of …